Blockchain and Internet of Medical Things for Resilient Healthcare
Bioengineering · 08.10.2026 · 13 (10) · 1173
DOI: 10.3390/bioengineering13101173 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 08.10.2026. Verfasst von Graziella Di Grezia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Health, and Health Professions, Link Campus University, 00165 Rome, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The COVID-19 pandemic exposed persistent weaknesses in health-data interoperability, cybersecurity, provenance, cross-organizational governance, and continuity of digital care. This short communication presents an updated focused narrative synthesis and a five-layer governance framework for integrating blockchain and the Internet of Medical Things (IoMT) in patient-centered digital health. The literature was updated through 10 August 2026, with recent peer-reviewed evidence complemented by authoritative standards and European regulatory sources. The synthesis positions blockchain primarily as a distributed governance, provenance, and audit layer rather than a clinical database or stand-alone security solution, while IoMT provides heterogeneous sensing infrastructure for continuous and distributed care. The framework separates: (1) device and data acquisition; (2) network and edge orchestration, including 5G/SDN where clinically justified; (3) blockchain-based governance; (4) privacy-enhancing data, analytics, and AI; and (5) application and service delivery. Homomorphic encryption, zero-knowledge proofs, secure aggregation, differential privacy, and federated learning are treated as complementary controls with distinct threat models and computational trade-offs. The revised framework also incorporates the European Health Data Space, the EU AI Act and its medical-device interplay, and NIS2 as a regulatory overlay. Across six use-case domains, evidence is strongest for technical feasibility, provenance, and programmable access control; evidence for clinical effectiveness, cost-effectiveness, equity, sustainability, and large-scale deployment remains limited. The proposed model therefore emphasizes standards-based interoperability, minimization of on-chain personal data, endpoint trust, auditable human oversight, and prospective real-world validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life Science, Health, and Health Professions, Link Campus University, 00165 Rome, Italy.
- RADIOCHAIN S.r.l., Academic Spin-Off of the University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
- Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
ORCID-Profile: Graziella Di Grezia, Alfredo Clemente, Stefano Dugheri, Vincenzo Mattei, Fabrizio Urraro, Nicola Mucci, Antonio Baldassarre
Zitieren
APA
Di Grezia, G., Clemente, A., Dugheri, S., Mattei, V., Gili, A., Mari, E., Urraro, F., Mucci, N., & Baldassarre, A. (2026). Blockchain and Internet of Medical Things for Resilient Healthcare. Bioengineering, 13(10), 1173. https://doi.org/10.3390/bioengineering13101173
Vancouver
Di Grezia G, Clemente A, Dugheri S, Mattei V, Gili A, Mari E, et al. Blockchain and Internet of Medical Things for Resilient Healthcare. Bioengineering. 2026;13(10):1173. doi:10.3390/bioengineering13101173
BibTeX
@article{DiGrezia2026,
author = {Di Grezia, Graziella and Clemente, Alfredo and Dugheri, Stefano and Mattei, Vincenzo and Gili, Alessio and Mari, Emanuela and Urraro, Fabrizio and Mucci, Nicola and Baldassarre, Antonio},
title = {Blockchain and Internet of Medical Things for Resilient Healthcare},
journal = {Bioengineering},
year = {2026},
volume = {13},
number = {10},
pages = {1173},
doi = {10.3390/bioengineering13101173}
}
EUVIMED